Acute cardiovascular events and malignancies risk in rheumatoid arthritis patients treated with tofacitinib or TNF inhibitors, a nationwide cohort study: RELATION study
Cardiologie
Rhumatologie
Oncologie
SNDS
communication-orale
Auteurs : Jacques-Eric Gottenberg, Nadir Mammar, Meriem Kessouri, Jeremie Rudant, Nada Assi, Benjamin Grenier, Julien Kirchgesner
Date de publication : 11 décembre 2022
